Parenting a child with phenylketonuria or galactosemia: implications for health-related quality of life

Amber E ten Hoedt, Heleen Maurice-Stam, Carolien C A Boelen, M Estela Rubio-Gozalbo, Francjan J van Spronsen, Frits A Wijburg, Annet M Bosch, Martha A Grootenhuis, Amber E ten Hoedt, Heleen Maurice-Stam, Carolien C A Boelen, M Estela Rubio-Gozalbo, Francjan J van Spronsen, Frits A Wijburg, Annet M Bosch, Martha A Grootenhuis

Abstract

Parents of children with chronic disorders have an impaired health-related quality of life (HRQoL) compared to parents of healthy children. Remarkably, parents of children with a metabolic disorder reported an even lower HRQoL than parents of children with other chronic disorders. Possibly, the uncertainty about the course of the disease and the limited life expectancy in many metabolic disorders are important factors in the low parental HRQoL. Therefore, we performed a cross-sectional study in parents of children with phenylketonuria (PKU, OMIM #261600) and galactosemia (OMIM #230400), metabolic disorders not affecting life expectancy, in order to investigate their HRQoL compared to parents of healthy children and to parents of children with other metabolic disorders. A total of 185 parents of children with PKU and galactosemia aged 1-19 years completed two questionnaires. Parents of children with PKU or galactosemia reported a HRQoL comparable to parents of healthy children and a significantly better HRQoL than parents of children with other metabolic disorders. Important predictors for parental mental HRQoL were the psychosocial factors emotional support and loss of friendship. As parental mental functioning influences the health, development and adjustment of their children, it is important that treating physicians also pay attention to the wellbeing of the parents. The insight that emotional support and loss of friendship influence the HRQoL of the parents enables treating physicians to provide better support for these parents.

References

    1. Arafa MA, Zaher SR, El-Dowaty AA, Moneeb DE. Quality of life among parents of children with heart disease. Health Qual Life Outcomes. 2008;6:91. doi: 10.1186/1477-7525-6-91.
    1. Bosch AM. Classical galactosaemia revisited. J Inherit Metab Dis. 2006;29:516–525. doi: 10.1007/s10545-006-0382-0.
    1. Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HS, Wijburg FA. Living with classical galactosemia: health-related quality of life consequences. Pediatrics. 2004;113:e423–e428. doi: 10.1542/peds.113.5.e423.
    1. Bruil J, Fekkes T, Vogels T, Verrips GHW (2004) TAAQOL Manual. Leiden Center for Child Health and Pediatrics LUMC-TNO
    1. Cohen J. Statistical power analysis for the behavioral sciences. 2. Hillsdale: Erlbaum; 1988.
    1. Friedman D, Holmbeck GN, Jandasek B, Zukerman J, Abad M. Parent functioning in families of preadolescents with spina bifida: longitudinal implications for child adjustment. J Fam Psychol. 2004;18:609–619. doi: 10.1037/0893-3200.18.4.609.
    1. Hatzmann J, Heymans HS, Ferrer-i-Carbonell A, van Praag BM, Grootenhuis MA. Hidden consequences of success in pediatrics: parental health-related quality of life–results from the Care Project. Pediatrics. 2008;122:e1030–e1038. doi: 10.1542/peds.2008-0582.
    1. Hatzmann J, Valstar MJ, Bosch AM, Wijburg FA, Heymans HS, Grootenhuis MA. Predicting health-related quality of life of parents of children with inherited metabolic diseases. Acta Paediatr. 2009;98:1205–1210. doi: 10.1111/j.1651-2227.2009.01269.x.
    1. Kazak AE, Reber M, Snitzer L. Childhood chronic disease and family functioning: a study of phenylketonuria. Pediatrics. 1988;81:224–230.
    1. Klassen AF, Klaassen R, Dix D, Pritchard S, Yanofsky R, O'Donnell M, Scott A, Sung L. Impact of caring for a child with cancer on parents' health-related quality of life. J Clin Oncol. 2008;26:5884–5889. doi: 10.1200/JCO.2007.15.2835.
    1. Lawoko S, Soares JJ. Quality of life among parents of children with congenital heart disease, parents of children with other diseases and parents of healthy children. Qual Life Res. 2003;12:655–666. doi: 10.1023/A:1025114331419.
    1. Moyle JJ, Fox AM, Arthur M, Bynevelt M, Burnett JR. Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU. Neuropsychol Rev. 2007;17:91–101. doi: 10.1007/s11065-007-9021-2.
    1. Pietz J, Dunckelmann R, Rupp A, et al. Neurological outcome in adult patients with early-treated phenylketonuria. Eur J Pediatr. 1998;157:824–830. doi: 10.1007/s004310050945.
    1. Pless IB, Nolan T. Revision, replication and neglect–research on maladjustment in chronic illness. J Child Psychol Psychiatry. 1991;32:347–365. doi: 10.1111/j.1469-7610.1991.tb00312.x.
    1. Prince M, Patel V, Saxena S, Maj M, Maselko J, Phillips MR, Rahman A. No health without mental health. Lancet. 2007;370:859–877. doi: 10.1016/S0140-6736(07)61238-0.
    1. Revicki DA, Osoba D, Fairclough D, Barofsky I, Berzon R, Leidy NK, Rothman M. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res. 2000;9:887–900. doi: 10.1023/A:1008996223999.
    1. Schmidt H, Burgard P, Pietz J, Rupp A. Intelligence and professional career in young adults treated early for phenylketonuria. Eur J Pediatr. 1996;155:S97–S100. doi: 10.1007/PL00014262.
    1. Scriver R, Levy H, Donlon J (2008) Hyperphenylalaninemia: Phenylalanine hydroxylase deficiency. In the online metabolic and molecular bases of inherited disease. Retrieved from: url:
    1. Snijders FAB, Bosker RJ. Multilevel analysis. An introduction to basic and advanced multilevel modeling. London: Sage; 2004.
    1. Wallander JL, Varni JW. Effects of pediatric chronic physical disorders on child and family adjustment. J Child Psychol Psychiatry. 1998;39:29–46. doi: 10.1017/S0021963097001741.
    1. Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response. Qual Life Res. 2001;10:405–413. doi: 10.1023/A:1012588218728.

Source: PubMed

3
Prenumerera